Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DX23FDENG
Awardee
Awarding agency
Obligated
$8,623

Award facts

Contract value 100% obligated
$8,622.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency Troop Support Medical (DLA) awarded a $8,622.70 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the supply of 4561558584 XTANDI 40 MG CAPSULE 120S. The place of performance is Park Ridge, Illinois. The period of performance is July 20, 2023 through July 21, 2023. DLA supports the Department of Defense by procuring pharmaceuticals and medical supplies. This delivery order was issued against an existing DLA contract vehicle to provide the prostate cancer medication Xtandi to authorized DoD customers. No subcontractors or set aside designations were identified.

Quick answers

Who was awarded contract SPE2DX23FDENG?

SPE2DX23FDENG was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 20, 2023.

How much is contract SPE2DX23FDENG worth?

The government has obligated $8,623 on SPE2DX23FDENG.

Is contract SPE2DX23FDENG an order under another contract?

Yes. SPE2DX23FDENG is a delivery order under SPE2DX15D9312, an indefinite delivery contract.

Was contract SPE2DX23FDENG competed?

The extent of competition for SPE2DX23FDENG was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award